Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL1136415 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292878 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL20570425 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL25285896 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292546 | 0.92 | GPR3 (0.48) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25301943 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25287606 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25255863 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL23430060 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL574924 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230140398-A1 | PRODUCTS COMPRISING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF OREGON (US) | 2023-05-04 | — | — | US | claimed |
| EP-4323327-B1 | METHODS FOR RECYCLING ETHYLENE IN AN ETHYLENE OLIGOMERIZATION REACTOR SYSTEM | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4429814-B1 | CHROMIUM BICYCLIC PHOSPHINYL AMIDINE COMPLEXES FOR TETRAMERIZATION OF ETHYLENE | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-4429813-B1 | CHROMIUM PHOSPHINYL HYDROISOINDOLE AMIDINE COMPLEXES FOR TETRAMERIZATION OF ETHYLENE | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-4429812-B1 | CHROMIUM PHOSPHINYL ISOINDOLE AMIDINE COMPLEXES FOR TETRAMERIZATION OF ETHYLENE | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-09-17 | — | — | EP | disclosed |
| CN-117337276-B | Process for recycling ethylene in an ethylene oligomerization reactor system | 切弗朗菲利浦化学公司 | 2025-02-07 | — | — | CN | disclosed |
| US-20240369507-A1 | ANION SENSING USING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORK NANOPARTICLES | UNIVERSITY OF OREGON (US) | 2024-11-07 | — | — | US | disclosed |
| US-12116330-B2 | Heat exchange configurations for oligomerization of olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-10-15 | — | — | US | disclosed |
| US-12102992-B2 | Machine learning and statistical analysis for catalyst structure prediction and design | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-10-01 | — | — | US | disclosed |
| EP-4429813-A1 | CHROMIUM PHOSPHINYL HYDROISOINDOLE AMIDINE COMPLEXES FOR TETRAMERIZATION OF ETHYLENE | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20080004459-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004441-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-01-03 | — | — | US | disclosed |
| US-7271121-B2 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-09-18 | — | — | US | disclosed |
| US-20070112150-A1 | Diimine metal complexes, methods of synthesis, and method of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2007-05-17 | — | — | US | disclosed |
| US-20070021608-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2007-01-25 | — | — | US | disclosed |
| US-7129304-B1 | Dimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2006-10-31 | — | — | US | disclosed |
| US-7056997-B2 | Catalyst composition and olefin polymerization using same | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2006-06-06 | — | — | US | disclosed |
| US-20050222350-A1 | Catalyst composition and olefin polymerization using same | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2005-10-06 | — | — | US | disclosed |
| US-6911506-B2 | Catalyst composition and olefin polymerization using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2005-06-28 | — | — | US | disclosed |
| US-20030149198-A1 | Catalyst composition and olefin polymerization using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2003-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240369507-A1 | ANION SENSING USING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORK NANOPARTICLES | TMEM63A, OR10J3, CA13 | CA1 43/4885CA2 40/4885CA7 255/4885 |
| US-20030149198-A1 | Catalyst composition and olefin polymerization using same | OXER1, ORC3, OSTC | CA1 1477/4885CA2 2936/4885CA7 2833/4885 |
| US-12116330-B2 | Heat exchange configurations for oligomerization of olefins | HEATR6, HEATR1, HSPA8 | CA1 4206/4885CA2 4336/4885CA7 4479/4885 |
| US-20080004441-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | PICALM, AP1M1, AP3M1 | CA1 1297/4885CA2 955/4885CA7 1934/4885 |
| US-20070021608-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | PICALM, AP1M1, AP3M1 | CA1 1297/4885CA2 955/4885CA7 1934/4885 |
| US-20230140398-A1 | PRODUCTS COMPRISING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USING THE SAME | TERF2IP, TERF2, TPM3 | CA1 1087/4885CA2 1586/4885CA7 3061/4885 |
| US-12102992-B2 | Machine learning and statistical analysis for catalyst structure prediction and design | MAX, CHRM4, SOD1 | CA1 1212/4885CA2 885/4885CA7 1387/4885 |
| US-20080004459-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | PICALM, AP1M1, AP2M1 | CA1 1076/4885CA2 666/4885CA7 1954/4885 |
| US-20070112150-A1 | Diimine metal complexes, methods of synthesis, and method of using in oligomerization and polymerization | PICALM, SPR, AP2M1 | CA1 2107/4885CA2 1338/4885CA7 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.